Schrödinger

Schrödinger has pioneered a distinctive platform that combines predictive physics-based approaches with machine learning techniques, aiming to expedite the drug discovery process. This platform is designed to evaluate and optimize chemical matter in silico ahead of synthesis and assay, which allows for the rapid identification of potent molecules suitable to initiate hit-to-lead and lead optimization efforts.